Lu-Jean Feng, M.D.
Medical Director, Founder Board-Certified Plastic and Reconstructive Surgeon
Scroll Down for More Content
As part of our standard protocol our pathologists screen for any and all abnormalities, looking for any microorganisms to include bacteria, yeast, and fungus as well as all cancers. Based upon their findings further tests will be conducted such as specific staining to test for cancer like CD30, culture and sensitivities, etc. As pertains to ALCL, it is standard practice for our pathologists to look for abnormal lymphocytes within the capsule. When abnormal lymphocytes are present, they will continue testing for the CD30 marker using immunofluorescent staining on samples taken from the capsule tissue. The CD30 positive cells that are in abnormal groupings or have abnormal morphology (shape and features) are indicative of ALCL. Flow cytometry can only be done on fluid, if fluid is found around the capsule this test may be performed. If not indicated by the initial pathology findings, the costs for additional testing for ALCL can range from $700-$2000, and may not be covered by insurance.
The recognized treatment for ALCL, according to the National Comprehensive Cancer Network, is removal of the implants and total capsulectomy (removal of the capsule.)